Eonhf, Inc.
Records under this name other than the patents Eonhf, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 36 patents it holds.
Showing 1 to 9 of 9 · Back to Eonhf, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,100,021 | CRYSTALLINE(2S,4R)-5-(5'-Chloro-2'-Fluoro-[1,1'-Bipheny]-4-YL)-2-(ETHOXYMETHYL)-4-(3-Hydroxyisoxazole-5-Carboxamido)-2-Methylpentanoic Acid and Uses Thereof Lapsed on the fee record Ended Oct 16, 2026 · Low confidence | Lapsed on the fee record | Ended Oct 16, 2026 | Low confidence |
| US 8,691,868 | Neprilysin Inhibitors Lapsed on the fee record Ended Apr 8, 2026 · High confidence | Lapsed on the fee record | Ended Apr 8, 2026 | High confidence |
| US 11,261,197 | Neprilysin inhibitors Lapsed on the fee record Ended Mar 1, 2026 · From the USPTO record | Lapsed on the fee record | Ended Mar 1, 2026 | From the USPTO record |
| US 9,884,807 | Neprilysin inhibitors Lapsed on the fee record Ended Feb 6, 2026 · From the USPTO record | Lapsed on the fee record | Ended Feb 6, 2026 | From the USPTO record |
| US 9,872,855 | (2R,4R)-5-(5'-Chloro-2'-Fluorobiphenyl-4-YL)-2-Hydroxy-4-[(5-Methyloxazole-2-Carbonyl)AMINO]PENTANOIC Acid Lapsed on the fee record Ended Jan 23, 2026 · High confidence | Lapsed on the fee record | Ended Jan 23, 2026 | High confidence |
| US 9,868,698 | (2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid Lapsed on the fee record Ended Jan 16, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jan 16, 2026 | From the USPTO record |
| US 9,845,332 | Neprilysin inhibitors Lapsed on the fee record Ended Dec 19, 2025 · From the USPTO record | Lapsed on the fee record | Ended Dec 19, 2025 | From the USPTO record |
| US 8,586,536 | Neprilysin Inhibitors Lapsed on the fee record Ended Nov 19, 2025 · High confidence | Lapsed on the fee record | Ended Nov 19, 2025 | High confidence |
| US 11,174,219 | Neprilysin inhibitors Lapsed on the fee record Ended Nov 16, 2025 · From the USPTO record | Lapsed on the fee record | Ended Nov 16, 2025 | From the USPTO record |